ArticleClinical Medicine Insights. Oncology2024

Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia.

Alaa Shahbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.